Offering mifepristone as an abortion option

Helen C. Pymar; Mitchell D Creinin

Offering mifepristone as an abortion option

Research output: Contribution to journal › Article › peer-review

Abstract

While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug still need to familiarize themselves with the research on its advantages and disadvantages.

Original language	English (US)
Pages (from-to)	113-119
Number of pages	7
Journal	Emergency Medicine
Volume	46
Issue number	2
State	Published - Feb 2001
Externally published	Yes

ASJC Scopus subject areas

Emergency Medicine
Emergency Medical Services

Access to Document

Fingerprint Dive into the research topics of 'Offering mifepristone as an abortion option'. Together they form a unique fingerprint.

Cite this

@article{ac6e905a58344ddf8ff827a0d8d2ab56,

title = "Offering mifepristone as an abortion option",

abstract = "While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug still need to familiarize themselves with the research on its advantages and disadvantages.",

author = "Pymar, {Helen C.} and Creinin, {Mitchell D}",

year = "2001",

month = feb,

language = "English (US)",

volume = "46",

pages = "113--119",

journal = "Emergency Medicine",

issn = "0013-6654",

publisher = "Quadrant Healthcom Inc.",

number = "2",

}

TY - JOUR

T1 - Offering mifepristone as an abortion option

AU - Pymar, Helen C.

AU - Creinin, Mitchell D

PY - 2001/2

Y1 - 2001/2

N2 - While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug still need to familiarize themselves with the research on its advantages and disadvantages.

AB - While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug still need to familiarize themselves with the research on its advantages and disadvantages.

UR - http://www.scopus.com/inward/record.url?scp=0004718253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0004718253&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0004718253

VL - 46

SP - 113

EP - 119

JO - Emergency Medicine

JF - Emergency Medicine

SN - 0013-6654

IS - 2

ER -